American Funds Short-Term Bond Fund of America® Class 529-F-1 (CFAMX) Sijoitusrahastokurssit ja uutiset

EtusivuCFAMX • Sijoitusrahasto

American Funds Short-Term Bond Fund of America® Class 529-F-1

9,59 $

17.4. · USD · MUTF · Vastuuvapauslauseke

American Funds Short-Term Bond Fund of America® Class R-1

9,41 $

RAMAX0,21 %

American Funds Short-Term Bond Fund of America® Class R-6

9,58 $

RMMGX0,10 %

American Funds Short-Term Bond Fund of America® Class 529-C

9,38 $

CCAMX0,11 %

American Funds Short-Term Bond Fund of America® Class 529-F-2

9,59 $

FTSBX0,21 %

American Funds Short-Term Bond Fund of America® Class R-4

9,59 $

RAMEX0,21 %

American Funds Short-Term Bond Fund of America® Class R-2E

9,56 $

RAAEX0,10 %

American Funds Short-Term Bond Fund of America® Class A

9,58 $

ASBAX0,10 %

American Funds Short-Term Bond Fund of America® Class R-2

9,40 $

RAMBX0,11 %

American Funds Short-Term Bond Fund of America® Class 529-E

9,57 $

CEAMX0,21 %

American Funds Short-Term Bond Fund of America® Class C

9,42 $

ASBCX0,21 %

Sijoitusrahasto

Viimeisin päätös

9,57 $

YTD-tuotto

0,19 %

Kulukerroin

0,72 %

Luokka

US Fixed Income

Morningstar Rating ‑luokitus

Nettovarallisuus

12,40 t. USD

Tuotto

3,99 %

Etukäteispalkkio

Perustamispäivä

16.11.2006

Pörssiuutiset

Yahoo Finance Singapore

1 tunti sitten

Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ

MarketPulse

30 minuuttia sitten

Chart alert: Nasdaq 100 gap-down stalled above 26,288/142 key support, bulls are still in control

Berkshire shares left behind as S&P 500 rallies to record high

Investor's Business Daily

3 tuntia sitten

Dow Jones Futures Fall, Oil Prices Jump; Trump Announces New Iran Talks With Hormuz Shut

Maplight Therapeutics, Inc.'s (NASDAQ:MPLT) Lock-Up Period To Expire on April 27th

MPLT

5,40 %

The Norfolk Daily News

1 päivä sitten

New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Viv